Publication date: Jul 03, 2026
A TAILORED, goal-focused therapy improved daily functioning in people with long COVID cognitive impairment, a randomised trial has found, delivering large and lasting benefits where no proven treatment has existed until now. A Treatment Gap in Long COVIDCognitive impairment is a common and disabling feature of long COVID, disrupting everyday life, yet no treatment has been proven to help. Researche .. .
| Concepts | Keywords |
|---|---|
| Adults | Care |
| Benefits | Cognitive |
| Everyday | Covid |
| February | Day |
| Therapy | Goal |
| Impairment | |
| Large | |
| Long | |
| Proven | |
| Randomised | |
| Received | |
| Rehabilitation | |
| Therapy | |
| Treatment | |
| Trial |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Long COVID |
| disease | MESH | Cognitive Impairment |
| drug | DRUGBANK | Ranitidine |
| disease | MESH | COVID-19 |
| disease | MESH | infection |
Original Article
(Visited 3 times, 1 visits today)